Clinical Trial Update: MUC1 Vaccine for Triple-negative Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 trial evaluating a MUC1 vaccine for breast cancer has completed its evaluation. The study targets inflammatory breast cancer and triple-n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• MUC1 vaccine (Mucin-1 vaccine)

Snippet

Sponsor: Joseph Baar, MD, PhD | Conditions: Breast Cancer, Inflammatory Breast Cancer | EARLY_Phase 1 | Status: COMPLETED